Fortrea Holdings Inc. (FTRE) NASDAQ
9.07
-0.48(-5.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.07
-0.48(-5.03%)
Currency In USD
| Previous Close | 9.55 |
| Open | 9.41 |
| Day High | 9.49 |
| Day Low | 8.98 |
| 52-Week High | 18.67 |
| 52-Week Low | 3.97 |
| Volume | 707,578 |
| Average Volume | 1.68M |
| Market Cap | 848.05M |
| PE | -0.84 |
| EPS | -10.81 |
| Moving Average 50 Days | 13 |
| Moving Average 200 Days | 10.48 |
| Change | -0.48 |
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
GlobeNewswire Inc.
Feb 17, 2026 12:00 PM GMT
Adds to executive focus on early clinical development and deepens medical and scientific partnership with clientsDURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
GlobeNewswire Inc.
Jan 29, 2026 1:08 PM GMT
DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the m
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 09, 2026 4:24 PM GMT
DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, at the J.P. Morgan Annual Heal